Snapshot

Investor Snapshot

Company

BARD1 Life Sciences Ltd

Description

BARD1 Life Sciences Ltd is an Australian based medical diagnostics company developing novel diagnostics for unmet needs in cancer

Headquarters

Melbourne, Australia

Employees

18

ASX Code

BD1 (listed 20 June 2016)

Sector

Healthcare

Shares on issue

2,394,530,384 effective 28th July 2020

Market Capitalisation

A$76.6M at A$0.032/share – closing price 24th July 2020

52 Week H/L

A$0.056 – 0.019 as at 24 July 2020

Board

Dr Geoff Cumming Chairman
Robert (Max) Johnston Non-Executive Director
Philip Powell Non-Executive Director
Professor Allan Cripps Non-Executive Director
Dr Irmgard Irminger-Finger Executive Director
Helen Fisher Non-Executive Director

Key Management

Dr Leearne Hinch Chief Executive Officer
Carl Stubbings Chief Operations Officer
Dr Peter French Chief Scientific Officer
Tony Di Pietro CFO & Company Secretary